Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 68

Results For "strategy"

783 News Found

Transcat acquires Tangent Labs for US $ 9 million
Medical Device | January 04, 2022

Transcat acquires Tangent Labs for US $ 9 million

Tangent offers ISO/IEC 17025-accredited calibrations and has labs located in both Indianapolis and Huntsville, Alabama


Tan Thanh Holdings to pre-purchase 10 million doses of Covid-19 oral vaccines for ASEAN region
Biotech | December 30, 2021

Tan Thanh Holdings to pre-purchase 10 million doses of Covid-19 oral vaccines for ASEAN region

Oravax's oral VLP vaccine in development targets three SARS CoV-2 virus surface proteins, including proteins less susceptible to mutation, thus making the vaccine potentially more effective against current and future variants of the Covid-19 virus


Comar expands packaging solutions with Omega acquisition
Packaging | December 30, 2021

Comar expands packaging solutions with Omega acquisition

The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise


Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA
Diagnostic Center | December 30, 2021

Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA

The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness


G42 Healthcare, Abu Dhabi and AstraZeneca to collaborate on clinical research
Biotech | December 29, 2021

G42 Healthcare, Abu Dhabi and AstraZeneca to collaborate on clinical research

G42 Healthcare and AstraZeneca will work closely together to explore real-world evidence and conduct clinical trials through IROS – the first-of-its-kind Contract Research Organization (CRO) in the UAE


Piramal Pharma takes a minority stake in Yapan Bio
Biotech | December 22, 2021

Piramal Pharma takes a minority stake in Yapan Bio

The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space


NMPA approves CStone's NDA for Cejemly
Drug Approval | December 21, 2021

NMPA approves CStone's NDA for Cejemly

The NMPA approval is based on the positive data of GEMSTONE-302 study, a multi-center, randomized, double-blind, phase III study that evaluated the efficacy and safety of Cejemly or placebo in combination with chemotherapy in first-line stage IV NSCLC patients


Beghou Consulting opens office in Pune to assist life sciences firms
News | December 20, 2021

Beghou Consulting opens office in Pune to assist life sciences firms

The company will collaborate with U.S.-based colleagues to help life sciences companies improve commercial effectiveness


Moderna says Covid-19 booster dose works against Omicron in lab study
News | December 20, 2021

Moderna says Covid-19 booster dose works against Omicron in lab study

Authorized booster increases Omicron neutralizing antibody levels approximately 37-fold


CellCarta acquires Biogazelle to strengthen its genomic capabilities
Medical Device | December 15, 2021

CellCarta acquires Biogazelle to strengthen its genomic capabilities

While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta's Center of Excellence for the development of complex genomic biomarker assays